MicroPort Scientific Corporation Net Assets

Latest as of December 2025: €1.50 Billion EUR ≈ $1.75 Billion USD

MicroPort Scientific Corporation net assets. Based on the latest financial reports, MicroPort Scientific Corporation (MSK) has net assets worth €1.50 Billion EUR (≈ $1.75 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€3.70 Billion ≈ $4.32 Billion USD) and total liabilities (€2.20 Billion ≈ $2.57 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore MicroPort Scientific Corporation (MSK) net asset momentum to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric Value
Current Net Assets €1.50 Billion
% of Total Assets 40.58%
Annual Growth Rate 11.87%
5-Year Change -32.35%
10-Year Change 332.98%
Growth Volatility 37.43

Net Assets of MicroPort Scientific Corporation (2013–2025)

Net assets of MicroPort Scientific Corporation from 2013 to 2025. This chart illustrates how MicroPort Scientific Corporation's net assets have evolved over time, based on quarterly financial data. See MicroPort Scientific Corporation net asset quality index to measure how much of total assets are equity-financed.

Annual Net Assets for MicroPort Scientific Corporation (2013–2025)

The table below shows the annual net assets of MicroPort Scientific Corporation from 2013 to 2025. For live market cap and overall valuation, see MSK market cap.

Year Net Assets Change
2025-12-31 €1.50 Billion
≈ $1.75 Billion
+31.04%
2024-12-31 €1.14 Billion
≈ $1.34 Billion
-18.40%
2023-12-31 €1.40 Billion
≈ $1.64 Billion
-21.74%
2022-12-31 €1.79 Billion
≈ $2.10 Billion
-19.16%
2021-12-31 €2.22 Billion
≈ $2.59 Billion
+59.77%
2020-12-31 €1.39 Billion
≈ $1.62 Billion
+112.24%
2019-12-31 €653.97 Million
≈ $764.55 Million
+23.64%
2018-12-31 €528.95 Million
≈ $618.39 Million
+20.36%
2017-12-31 €439.45 Million
≈ $513.77 Million
+26.83%
2016-12-31 €346.48 Million
≈ $405.07 Million
+9.01%
2015-12-31 €317.83 Million
≈ $371.57 Million
-7.54%
2014-12-31 €343.74 Million
≈ $401.87 Million
-11.96%
2013-12-31 €390.43 Million
≈ $456.46 Million
--

Equity Component Analysis

This analysis shows how different components contribute to MicroPort Scientific Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 1407.9% over the analyzed period, potentially due to dividend distributions or operating losses.

MicroPort Scientific Corporation Net Assets Breakdown (December 2025)

MicroPort Scientific Corporation net assets breakdown by equity component as of December 2025.

Component Amount Percentage
Other Components €2.53 Billion 257.74%
Total Equity €980.82 Million 100.00%

MicroPort Scientific Corporation Competitors by Market Cap

The table below lists competitors of MicroPort Scientific Corporation ranked by their market capitalization.

Company Market Cap
FAP Agri Tbk PT
JK:FAPA
$1.45 Billion
Allient Inc.
NASDAQ:ALNT
$1.46 Billion
Harbin Hatou Investment Co Ltd
SHG:600864
$1.46 Billion
Shinsegae
KO:004170
$1.46 Billion
TES Co. Ltd
KQ:095610
$1.45 Billion
Telecom Argentina SA ADR
NYSE:TEO
$1.45 Billion
Offcn Education Technology Co Ltd
SHE:002607
$1.45 Billion
Adecoagro S.A
F:ACD
$1.45 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in MicroPort Scientific Corporation's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 603,473,000 to 980,815,000, a change of 377,342,000 (62.5%).
  • Net income of 48,519,000 contributed positively to equity growth.
  • Other factors increased equity by 337,058,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income €48.52 Million +4.95%
Other Changes €337.06 Million +34.37%
Total Change €- 62.53%

Book Value vs Market Value Analysis

This analysis compares MicroPort Scientific Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.27x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 2.36x to 1.27x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 €0.28 €0.65 x
2018-12-31 €0.28 €0.65 x
2019-12-31 €0.32 €0.65 x
2020-12-31 €0.62 €0.65 x
2021-12-31 €0.82 €0.65 x
2022-12-31 €0.62 €0.65 x
2023-12-31 €0.41 €0.65 x
2024-12-31 €0.33 €0.65 x
2025-12-31 €0.51 €0.65 x

Capital Efficiency Dashboard

This dashboard shows how efficiently MicroPort Scientific Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 4.95%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 4.88%
  • • Asset Turnover: 0.27x
  • • Equity Multiplier: 3.77x
  • Recent ROE (4.95%) is above the historical average (-12.26%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2013 6.15% 15.82% 0.29x 1.33x €-15.05 Million
2014 -17.37% -16.74% 0.38x 2.75x €-93.69 Million
2015 -3.87% -3.22% 0.51x 2.35x €-43.34 Million
2016 4.25% 3.63% 0.50x 2.33x €-19.15 Million
2017 4.69% 4.24% 0.49x 2.25x €-21.34 Million
2018 5.40% 3.57% 0.53x 2.88x €-20.37 Million
2019 8.92% 5.83% 0.50x 3.08x €-5.62 Million
2020 -16.96% -29.48% 0.26x 2.19x €-304.05 Million
2021 -18.55% -35.51% 0.18x 2.94x €-425.56 Million
2022 -38.46% -51.91% 0.21x 3.52x €-550.02 Million
2023 -63.03% -50.24% 0.24x 5.19x €-553.41 Million
2024 -35.47% -23.16% 0.25x 6.02x €-274.39 Million
2025 4.95% 4.88% 0.27x 3.77x €-49.56 Million

Industry Comparison

This section compares MicroPort Scientific Corporation's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $43,182,789,693
  • Average return on equity (ROE) among peers: -61.19%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
MicroPort Scientific Corporation (MSK) €1.50 Billion 6.15% 1.46x $1.45 Billion
LEPU MED.T.B. SP.GDR O.N. (07Z0) $17.50 Billion 7.19% 0.43x $167.03K
BIORETEC OY (0TN) $1.92 Million -125.78% 0.82x $16.10 Million
SYSMEX CORP.UNSP.ADR 1/2 (0YX0) $388.36 Billion 11.79% 0.37x $4.70 Billion
INMODE LTD IS -01 (154) $554.62 Million 29.12% 0.16x $711.77 Million
HeraMED Limited (1I4) $931.03K -443.77% 0.60x $27.68 Million
Medtronic PLC (2M6) $19.44 Billion 15.76% 0.95x $83.04 Billion
Peijia Medical Limited (4WO) $3.02 Billion -19.02% 0.05x $330.31 Million
AVITA Medical Inc (51KB) $84.74 Million -31.47% 0.16x $172.49 Million
BRAINCOOL AB (5YL) $116.23 Million -39.24% 0.15x $18.88 Million
MICROPORT CARDIO.MEDTECH. (72X) $2.75 Billion -16.50% 0.09x $107.57 Million

About MicroPort Scientific Corporation

F:MSK Germany Medical Devices
Market Cap
$1.45 Billion
€1.24 Billion EUR
Market Cap Rank
#7070 Global
#1014 in Germany
Share Price
€0.65
Change (1 day)
+0.00%
52-Week Range
€0.64 - €1.37
All Time High
€7.69
About

MicroPort Scientific Corporation, together with its subsidiaries, engages in the innovating, manufacturing, and marketing medical devices globally in the People's Republic of China, the United States of America, Europe, Middle East and Africa, Japan, and internationally. The company's Cardiovascular Devices segment offers medical solutions for the treatment of coronary artery-related diseases; an… Read more